Journal of the Neurological Sciences
Volume 201, Issue 1 , Pages 13-17 , 15 September 2002

Long-term impact on work and private life after Guillain–Barré syndrome

  • Robert A.J.A.M Bernsen

      Affiliations

    • Corresponding Author InformationCorresponding author. Fax: +31-50-361-1707
    • Department of Neurology, University Hospital, PO Box 30.001, 9700 RB Groningen, The Netherlands
  • ,
  • Aeiko E.J de Jager

      Affiliations

    • Department of Neurology, University Hospital, PO Box 30.001, 9700 RB Groningen, The Netherlands
  • ,
  • Paul I.M Schmitz

      Affiliations

    • Department of Biostatistics, University Hospital and Erasmus University, PO Box 2040, 3000 CA Rotterdam, The Netherlands
  • ,
  • Frans G.A van der Meché

      Affiliations

    • Department of Neurology, University Hospital and Erasmus University, PO Box 2040, 3000 CA Rotterdam, The Netherlands

Received 18 December 2001 ,Revised 20 May 2002 ,Accepted 21 May 2002.

References 

  1. De Jager AEJ, Minderhoud JM. Residual signs in severe Guillain–Barré syndrome: Analysis of 57 patients. J. Neurol. Sci. 1991;104:151–156
  2. Italian Guillain–Barré Study Group . The prognosis and main prognostic indicators of Guillain–Barré syndrome. Brain. 1996;119:2053–2061
  3. Plasma Exchange/Sandoglobulin Guillain–Barré Trial Group . Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain–Barré syndrome. Lancet. 1997;349:225–230
  4. Vedeler CA, Wik E, Nyland H. The long term prognosis of Guillain–Barré syndrome. Evaluation of prognostic factors including plasma exchange. Acta Neurol. Scand. 1997;95:298–302
  5. Löffel NB, Rossi LN, Mumenthaler M, Lutschg J, Ludin HP. The Landry–Guillain–Barré syndrome. J. Neurol. Sci. 1977;33:71–79
  6. Rice D. Landry–Guillain–Barré syndrome: Personal experience of acute ascending paralysis. Br. Med. J. 1977;1:1330–1332
  7. Lennon SM, Koblar S, Hughes RAC, Goeller J, Riser AC. Reasons for persistent disability in Guillain–Barré syndrome. Clin. Rehabil. 1993;7:1–8
  8. Chemtob CM, Herriott MG. Post-traumatic stress disorder as a sequela of Guillain–Barré syndrome. J. Trauma Stress. 1994;7:705–711
  9. Bakker-Hatten BS, Lankhorst GJ, Kriek L, Slootman JR. Functional outcome of Guillain–Barré syndrome. J. Rehabil. Sci. 1995;8:82–86
  10. Gregory RJ. Understanding and coping with neurological impairment. Rehabil. Nurs. 1995;20:74–78
  11. Meythaler JM. Rehabilitation of Guillain–Barré syndrome. Arch. Phys. Med. Rehabil. 1997;78:872–879
  12. Van der Meché FGA, Schmitz PIM  Dutch Guillain–Barré Study Group . A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain–Barré syndrome. N. Engl. J. Med. 1992;326:1123–1129
  13. DeJong RN. In: The Neurological Examination. 5th ed.. New York: Harper and Row; 1992;p. 151–173
  14. Bernsen RAJAM, de Jager AEJ, Schmitz PIM, Van der Meché FGA. Residual physical outcome and daily living 3 to 6 years after Guillain–Barre syndrome. Neurology. 1999;53:409–410
  15. Bernsen RAJAM, de Jager AEJ, Schmitz PIM, Van der Meché FGA. Long-term sensory deficit after Guillain–Barre syndrome. J. Neurol. 2001;248:483–486
  16. Asbury AK, Arnason BWG, Karp HR, Mc Farlin DE. Criteria for the diagnosis of Guillain–Barré syndrome. Ann. Neurol. 1978;3:565–566
  17. Burrows DS. Residual subclinical impairment in patients who totally recovered from Guillain–Barré syndrome: Impact on military performance. Mil. Med. 1990;155:438–440
  18. Greenwald HP, Dirks JD, Borgatta EF, McCorkle R, Nevitt MC, Yelin EH. Work disability among cancer patients. Soc. Sci. Med. 1989;29:1253–1259
  19. In:  Dyck PJ,  Thomas PK editor. Diabetic Neuropathy. 2nd ed.. Philadelphia: W.B. Saunders; 1999;p. 240
  20. Teunissen LL, Eurelings M, Notermans NC, Hop JW, van Gijn J. Quality of life in patients with axonal polyneuropathy. J. Neurol. 2000;247:195–199
  21. Zifko UA. Long-term outcome of critical illness polyneuropathy. Muscle Nerve. 2000;Suppl. 9:S49–S52

PII: S0022-510X(02)00158-2

Journal of the Neurological Sciences
Volume 201, Issue 1 , Pages 13-17 , 15 September 2002